Registration is often described as a black box: documents go in, a certificate comes out, timelines are unpredictable. In practice the unpredictable part is smaller than it looks. Most delays come from the dossier itself — from documents that were missing, outdated or issued in a form that cannot be used.
Classification comes first
Everything else follows from the product class: the depth of the dossier, whether laboratory testing is required, which safety data must be presented and how long the review takes. A dermal filler, a cosmetic line and a device with an active component are three different procedures, even when they are sold to the same clinic.
What is usually already in place
A European manufacturer normally holds most of what is needed:
- quality system certificates and the CE documentation package;
- product specification, composition and technical file;
- clinical evaluation and post-market safety data;
- free sale certificate from the country of origin;
- artwork for labels, packaging and the instructions for use.
The work is not to create these documents, but to bring them into a form the regulator accepts: current validity dates, correct legalisation, consistent product naming across every file.
Where dossiers usually stall
Three recurring problems account for most of the lost time. Names that differ between the certificate, the specification and the packaging. Documents that expire during the review. Translations made without regulatory context, where a term from the technical file becomes a different term in the instructions for use.
None of these are complicated to prevent, and all of them are expensive to fix after submission — a request from the regulator restarts a part of the timeline.
Labelling and instructions for the local market
Labelling and the instructions for use are prepared for the market, not translated from the original word for word. They carry the information a physician and an inspector will look for, in the languages of the market. It is the part of the dossier the manufacturer controls entirely, and the part most often left to the last week.
A realistic timeline
Timelines depend on the product class, on the completeness of the dossier and on whether testing is required. What can be planned is the preparation: with the documents collected and checked in advance, the submission stops being the bottleneck — and the launch date becomes a date the commercial team can actually work with.